Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-23T13:17:24.308Z Has data issue: false hasContentIssue false

Importance of adhesion molecules for children with congenital heart disease

Published online by Cambridge University Press:  16 April 2012

Ayşe Yıldırım*
Affiliation:
Department of Pediatric Cardiology, Istanbul, Turkey
Aysu T. Karaağaç
Affiliation:
Department of Pediatry, Istanbul, Turkey
Fusun Güzelmeriç
Affiliation:
Department of Anesthesiology and Reanimation, Istanbul, Turkey
Nihat Çine
Affiliation:
Department of Cardiovascular Surgery, Istanbul, Turkey
Naci C. Öner
Affiliation:
Department of Pediatric Cardiology, Istanbul, Turkey
*
Correspondence to: A. Yıldırım, Kartal Koşuyolu Yüksek İhtisas Eğitim ve Araştırma Hastanesi, Denizer Caddesi Cevizli Kavşağı No: 2, 34846 Kartal/Istanbul, Turkey. Tel: +90 2164594440; Fax: +90 2164596321; E-mail: [email protected]

Abstract

Background

The aim of our study was to compare the blood levels of adhesion molecules in children with different heart diseases and pulmonary flow rates.

Methods

In this study, we evaluated the levels of soluble intercellular adhesion molecule-1 and soluble vascular cellular adhesion molecule-1 in blood samples of 65 children with different congenital heart diseases. The patients were divided into four groups according to their pulmonary blood flow. The first group had increased pulmonary blood flow with pulmonary hypertension and left-to-right shunt. The second group had increased pulmonary blood flow without pulmonary hypertension and left-to-right shunt. The third group had decreased pulmonary blood flow with cyanotic congenital heart disease and the fourth group had normal pulmonary blood flow with left ventricle outflow tract obstruction and aortic stenosis.

Result

The highest soluble intercellular and vascular cellular adhesion molecule-1 levels with the mean values of 420.2 nanograms per millilitre and 1382.1 nanograms per millilitre, respectively, were measured in the first group and the lowest levels with the mean values of 104.4 and 358.6 nanograms per millilitre, respectively, were measured in the fourth group. The highest pulmonary blood pressure levels were found in the first group.

Conclusion

Endothelial activity is influenced not only by left-to-right shunt with pulmonary hypertension, but also by decreased pulmonary blood flow in cyanotic heart diseases. Adhesion molecules are valuable markers of endothelial activity in congenital heart diseases, and they are influenced by pulmonary blood flow rate.

Type
Original Article
Copyright
Copyright © Cambridge University Press 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Springer, TA. Adhesion receptors of the immune system. Nature 1990; 346: 425434.CrossRefGoogle ScholarPubMed
2. Gearing, AJH, Newman, W. Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506512.Google Scholar
3. Wang, H, Nawata, J, Kakudo, N, et al. The upregulation of ICAM-1 and P-selectin requires high blood pressure but not circulating renin–angiotensin system in vivo. J Hypertens 2004; 22: 13231332.CrossRefGoogle Scholar
4. Kotlyar, E, Vita, JA, Winter, MR, et al. The relationship between aldosterone, oxidative stress, and inflammation in chronic, stable human heart failure. J Card Fail 2006; 12: 122127.Google Scholar
5. Rohatgi, A, Owens, AW, Khera, A, et al. Differential associations between soluble cellular adhesion molecules and atherosclerosis in the Dallas Heart Study: a distinct role for soluble endothelial cell-selective adhesion molecule. Arterioscler Thromb Vasc Biol 2009; 29: 16841690.Google Scholar
6. Kluz, J, Kopeć, W, Jakobsche-Policht, U, Adamiec, R. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis. Int Angiol 2009; 28: 192201.Google ScholarPubMed
7. Mendoza-Carrera, F, Ojeda-Durán, S, Angulo, E, et al. Influence of cytokine and intercellular adhesion molecule-1 gene polymorphisms on acute rejection in pediatric renal transplantation. Pediatr Transplant 2008; 12: 755761.CrossRefGoogle ScholarPubMed
8. Rabinovitch, M. Pulmonary hypertension: pathophysiology as a basis for clinical decision making. J Heart Lung Transplant 1999; 11: 10411053.Google Scholar
9. Boldt, J, Wollbruck, M, Kuhn, D, Linke, LC, Hempelmann, G. Do plasma levels of circulating soluble adhesion molecules differ between surviving and nonsurviving critically ill patients? Chest 1995; 107: 787792.Google Scholar
10. Cowley, HC, Heney, D, Gearing, AJH. Increased circulating adhesion molecule concentrations in patients with septic inflammatory response: a prospective cohort study. Crit Care Med 1994; 22: 651665.CrossRefGoogle ScholarPubMed
11. Eikemo, H, Sellevold, OF, Videm, V. Markers for endothelial activation during open heart surgery. Ann Thorac Surg 2004; 77: 214219.CrossRefGoogle ScholarPubMed
12. Sungprem, K, Khongphatthanayothin, A, Kiettisanpipop, P, Chotivitayatarakorn, P, Poovorawan, Y, Lertsapcharoen, P. Serum level of soluble intercellular adhesion molecule-1 correlates with pulmonary arterial pressure in children with congenital heart disease. Pediatr Cardiol 2009; 30: 472476.CrossRefGoogle ScholarPubMed
13. Muller, WA. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the in ammatory response. Trends Immunol 2003; 24: 327334.CrossRefGoogle Scholar
14. Galley, HF, Webster, NR. Physiology of the endothelium. Br J Anaesth 2004; 93: 105113.CrossRefGoogle ScholarPubMed
15. Blume, ED, Nelson, DP, Gauvreau, K, et al. Soluble adhesion molecules in infants and children undergoing cardiopulmonary bypass. Circulation 1997; 4 96: 352357.Google Scholar
16. Cordina, RL, Celermajer, DS. Chronic cyanosis and vascular function: implications for patients with cyanotic congenital heart disease. Cardiol Young 2010; 20: 242253.Google Scholar
17. Setty, BN, Stuart, MJ, Dampier, C, Brodecki, D, Allen, JL. Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology. Lancet 2003; 362: 14501455.Google Scholar
18. Rother, RP, Bell, L, Hillmen, P, Gladwin, MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005; 293: 16531662.Google Scholar